BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12703219)

  • 61. Chemoembolization of hepatoma.
    Gross KA; Kinnison M
    J Vasc Nurs; 2004 Jun; 22(2):64-5. PubMed ID: 15179420
    [No Abstract]   [Full Text] [Related]  

  • 62. [Local treatment of liver tumors].
    Pless TK; Skjoldbye BO
    Ugeskr Laeger; 2008 Apr; 170(16):1348-9. PubMed ID: 18433596
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists.
    Fusco N; Bosari S
    World J Gastroenterol; 2016 Sep; 22(35):7926-37. PubMed ID: 27672288
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Liver, pancreas, biliary tract cancer].
    Miyazaki M
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1477. PubMed ID: 23130370
    [No Abstract]   [Full Text] [Related]  

  • 65. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
    Schumacher G; Gebauer B
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
    [No Abstract]   [Full Text] [Related]  

  • 66. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.
    Morante A; Romano M; Cuomo A; de Sio I; Cozzolino A; Mucherino C; Salerno R; Blanco Cdel V; Romano M
    Gastrointest Endosc; 2006 Apr; 63(4):718-20. PubMed ID: 16564887
    [No Abstract]   [Full Text] [Related]  

  • 67. Role of liver transplantation for hepatobiliary malignant disorders.
    Marsh JW; Geller DA; Finkelstein SD; Donaldson JB; Dvorchik I
    Lancet Oncol; 2004 Aug; 5(8):480-8. PubMed ID: 15288237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatocellular carcinoma.
    Naugler WE; Schwartz JM
    Dis Mon; 2008 Jul; 54(7):432-44. PubMed ID: 18570913
    [No Abstract]   [Full Text] [Related]  

  • 69. Multiple intrahepatic implantations of hepatocellular carcinoma following percutaneous ethanol injection (PEI) therapy.
    Petsas T; Kalogeropoulou C; Tsota I; Tsamandas AC
    Liver Int; 2006 Apr; 26(3):382-4. PubMed ID: 16584403
    [No Abstract]   [Full Text] [Related]  

  • 70. Case 3. Grey-Turner's sign as the first indication of a ruptured hepatocellular carcinoma.
    Sevastianos VA; Deutsch M; Dourakis SP
    J Clin Oncol; 2004 Mar; 22(6):1156-7. PubMed ID: 15020619
    [No Abstract]   [Full Text] [Related]  

  • 71. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
    Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fibrolamellar hepatocellular carcinoma.
    Liu S; Chan KW; Wang B; Qiao L
    Am J Gastroenterol; 2009 Oct; 104(10):2617-24; quiz 2625. PubMed ID: 19638962
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Home to Benin.
    Burch KA
    J Clin Oncol; 2005 Oct; 23(28):7226-9. PubMed ID: 16192609
    [No Abstract]   [Full Text] [Related]  

  • 74. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes?
    Di Bisceglie AM
    Liver Transpl; 2005 Nov; (11 Suppl 2):S10-3. PubMed ID: 16237728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Tumors of the liver and biliary system].
    Chlumská A
    Vnitr Lek; 1997 Mar; 43(3):154-6. PubMed ID: 9221574
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Treatment of metastatics colorectal cancer to the liver].
    Zhao P; Wang CF; Li YS
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2094-6. PubMed ID: 16313815
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour.
    Mentha G; Majno P; Terraz S; Rubbia-Brandt L; Gervaz P; Andres A; Allal AS; Morel P; Roth AD
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S76-83. PubMed ID: 18006267
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?
    Zhu AX
    Oncologist; 2006; 11(7):790-800. PubMed ID: 16880238
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pancreatic and hepatobiliary cancers: adjuvant therapy and management of inoperable disease.
    Glimelius B
    Ann Oncol; 2000; 11 Suppl 3():153-9. PubMed ID: 11079133
    [No Abstract]   [Full Text] [Related]  

  • 80. [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].
    Kudo M; Chung H; Osaki Y; Kasugai H; Oka H; Seki T
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2100-4. PubMed ID: 15628751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.